argenx SE (argenx SE) Price-to-Operating-Cash-Flow : (As of Apr. 26, 2024)

View and export this data going back to 2017. Start your Free Trial

What is argenx SE Price-to-Operating-Cash-Flow?

As of today (2024-04-26), argenx SE's share price is $372.64. argenx SE's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Hence, argenx SE's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for argenx SE's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, argenx SE's highest Price-to-Operating-Cash-Flow Ratio was 835.33. The lowest was 586.67. And the median was 626.67.

ARGX's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.725
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

argenx SE's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.20% per year.

During the past 13 years, argenx SE's highest 3-Year average Operating Cash Flow per Share Growth Rate was 84.70% per year. The lowest was -86.50% per year. And the median was -26.20% per year.

argenx SE Price-to-Operating-Cash-Flow Historical Data

The historical data trend for argenx SE's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Price-to-Operating-Cash-Flow Chart

argenx SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

40.63

argenx SE Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of argenx SE's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, argenx SE's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

argenx SE's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where argenx SE's Price-to-Operating-Cash-Flow falls into.

argenx SE Price-to-Operating-Cash-Flow Calculation

argenx SE's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	372.64	/	0
	=

argenx SE's Share Price of today is $372.64.
argenx SE's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

argenx SE Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of argenx SE's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

argenx SE (argenx SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ARGX:Mexico ARGXb:UK 0QW0:UK 1AEA:Germany 1AE:Germany 1AE:Germany A1RG34:Brazil ARGX:Belgium ARGX:Austria

Address

Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB

Website

https://www.argenx.com

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.